We are live on ! Find out more
Connor, Clark & Lunn Investment Management (CC&L)

Connor, Clark & Lunn Investment Management (CC&L) Portfolio holdings

AUM $43.4B
1-Year Est. Return 51.29%
This Fund
S&P 500
This Quarter Est. Return
-14.29%
1 Year Est. Return
+51.29%
3 Year Est. Return
+133.48%
5 Year Est. Return
+173.9%
10 Year Est. Return
+551.09%
AUM
$16.5B
AUM Growth
-$3.93B
Cap. Flow
-$718M
Cap. Flow %
-4.36%
Top 10 Hldgs %
32.53%
Holding
1,265
New
250
Increased
403
Reduced
360
Closed
243

Top Buys

Rank Stock Value
1
CNI icon
Canadian National Railway
CNI
+$87M
2
QSR icon
Restaurant Brands International
QSR
+$63.5M
3
BIP icon
Brookfield Infrastructure Partners
BIP
+$62.1M
4
AZN icon
AstraZeneca
AZN
+$55.4M
5
AQN icon
Algonquin Power & Utilities
AQN
+$54.6M

Top Sells

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$159M
2
RY icon
Royal Bank of Canada
RY
+$100M
3
VRN
Veren
VRN
+$89.9M
4
WPM icon
Wheaton Precious Metals
WPM
+$88.9M
5
GOOG icon
Alphabet (Google) Class C
GOOG
+$78.3M

Sector Composition

Rank Sector Weight
1 Financials 27.58%
2 Energy 14.56%
3 Industrials 13.17%
4 Technology 10.16%
5 Materials 9.15%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
QTRX icon
951
Quanterix
QTRX
$137M
$169K ﹤0.01%
10,459
-6,588
-39% -$135K
FIRY
952
Firy Inc
FIRY
$158M
$166K ﹤0.01%
6,701
-35,503
-84% -$1.39M
PRCH icon
953
Porch Group
PRCH
$1.9B
$165K ﹤0.01%
+64,600
New +$267K
PVLA
954
Palvella Therapeutics
PVLA
$2.22B
$165K ﹤0.01%
1,106
-775
-41% -$141K
DTIL icon
955
Precision BioSciences
DTIL
$199M
$163K ﹤0.01%
3,405
+3,017
+778% +$177K
BBIO icon
956
BridgeBio Pharma
BBIO
$15.9B
$153K ﹤0.01%
16,849
-351,105
-95% -$2.94M
LFVN icon
957
LifeVantage
LFVN
$81M
$150K ﹤0.01%
34,377
-10,294
-23% -$44.9K
VHC icon
958
VirnetX Holding Corp
VHC
$67.6M
$149K ﹤0.01%
6,352
+3,630
+133% +$101K
SND icon
959
Smart Sand
SND
$214M
$148K ﹤0.01%
74,167
+46,673
+170% +$161K
DRD
960
DRDGold
DRD
$2.07B
$145K ﹤0.01%
24,722
-4,980
-17% -$36.9K
NKTR icon
961
Nektar Therapeutics
NKTR
$2.56B
$144K ﹤0.01%
2,522
-8,710
-78% -$550K
AMSC icon
962
American Superconductor
AMSC
$1.56B
$143K ﹤0.01%
+27,667
New +$160K
ADVM
963
DELISTED
Adverum Biotechnologies
ADVM
$141K ﹤0.01%
11,751
-18,521
-61% -$194K
AFMD
964
DELISTED
Affimed
AFMD
$138K ﹤0.01%
4,972
-18,355
-79% -$628K
EMWP
965
DELISTED
Eros Media World PLC
EMWP
$138K ﹤0.01%
+57,473
New +$130K
ASYS icon
966
Amtech Systems
ASYS
$284M
$136K ﹤0.01%
18,660
-8,595
-32% -$74.2K
GLDG
967
GoldMining Inc
GLDG
$223M
$136K ﹤0.01%
145,700
-46,700
-24% -$59.5K
STRO icon
968
Sutro Biopharma
STRO
$352M
$135K ﹤0.01%
+2,593
New +$145K
NL icon
969
NLI Holdings
NL
$324M
$132K ﹤0.01%
13,329
+311
+2% +$2.5K
KYNB
970
Kyntra Bio
KYNB
$28.7M
$124K ﹤0.01%
471
-1,368
-74% -$350K
BLDP
971
Ballard Power Systems
BLDP
$793M
$121K ﹤0.01%
+19,200
New +$154K
ACIC icon
972
American Coastal Insurance
ACIC
$461M
$118K ﹤0.01%
75,524
-29,506
-28% -$62.6K
MTRX icon
973
Matrix Service
MTRX
$330M
$118K ﹤0.01%
+23,278
New +$146K
SCOR icon
974
Comscore
SCOR
$90.9M
$115K ﹤0.01%
2,789
-10,371
-79% -$431K
ERO icon
975
Ero Copper
ERO
$3.57B
$112K ﹤0.01%
13,300
-192,400
-94% -$2.4M
37 38
39
40 41

Similar funds

State of Wisconsin Investment Board
State of Wisconsin Investment Board Madison, Wisconsin $43.7B AUM 27.76% 1-Year Est. Return
WCM Investment Management
WCM Investment Management Laguna Beach, California $43.8B AUM 42.28% 1-Year Est. Return
PEAK6
PEAK6 Chicago, Illinois $42.6B AUM 66.24% 1-Year Est. Return
TCI Fund Management
TCI Fund Management London, United Kingdom $45.2B AUM 12.74% 1-Year Est. Return
Holocene Advisors
Holocene Advisors New York $41.5B AUM 42.97% 1-Year Est. Return
LP
LMR Partners London, United Kingdom $45.4B AUM 60.47% 1-Year Est. Return
HF
HRT Financial New York $40.1B AUM 58.22% 1-Year Est. Return
TI
Tidal Investments Milwaukee, Wisconsin $47.4B AUM 59.58% 1-Year Est. Return

Connor, Clark & Lunn Investment Management (CC&L)'s Q2 2022 Portfolio in Review

As of Q2 2022, Connor, Clark & Lunn Investment Management (CC&L) held 1,265 positions worth $16.5B, down 19% from $20.4B the previous quarter. Its ten largest holdings account for 33% of the portfolio.

Connor, Clark & Lunn Investment Management (CC&L) withdrew a net $718M in Q2 2022, closing 243 positions and reducing 360 holdings. Its most notable exit was Alibaba, an estimated $44.8M position sold in full.

By sector, the portfolio is most concentrated in Financials at 28% of assets, up from 27% a quarter earlier, followed by Energy and Industrials.

Against the trend, Connor, Clark & Lunn Investment Management (CC&L) opened a new position in GSK worth $49.3M.

  • Connor, Clark & Lunn Investment Management (CC&L)'s largest Q2 2022 buy was GSK: 905,598 shares worth $49.3M.
  • Connor, Clark & Lunn Investment Management (CC&L) added most to Canadian National Railway in Q2 2022, an estimated $87M increase.
  • Connor, Clark & Lunn Investment Management (CC&L)'s biggest Q2 2022 reduction was Apple, cutting an estimated $159M.
  • Connor, Clark & Lunn Investment Management (CC&L) fully exited Alibaba in Q2 2022, selling an estimated $44.8M.
  • Connor, Clark & Lunn Investment Management (CC&L)'s ten largest holdings make up 33% of its $16.5B portfolio in Q2 2022.
  • Connor, Clark & Lunn Investment Management (CC&L) opened 250 new positions and closed 243 in Q2 2022.
  • Connor, Clark & Lunn Investment Management (CC&L)'s portfolio value fell 19% quarter-over-quarter to $16.5B.

Based on Connor, Clark & Lunn Investment Management (CC&L)'s 13F filing for Q2 2022, filed 5 Aug 2022.